Peptide sequencing using mass spectrometry
WO1994006017A1 · Selectide Corporation · priority 1992
| Patent | WO1994006017A1 ↗ |
| Status | Ceased |
| Priority date | 1992-09-03 |
| Filed | 1993-09-02 |
| Published | 1994-03-17 |
| Assignee | Selectide Corporation (printed Selectide Corp) |
| Also published as | AU4844893A, US5470753A |
Abstract
The present invention relates to methods for determining the amino acid composition, and more preferably the sequence, of a peptide using mass spectrometric techniques. The method is particularly useful for sequencing peptides isolated from natural sources or from libraries of peptides that have been prepared synthetically, and for peptides that are not amenable to Edman degradation sequencing. In one embodiment, the method for determining the amino acid composition or sequence of a peptide comprises determining the difference of the mass of the peptide from the mass of a deuterium-hydrogen exchanged peptide, and from this difference determining the number of exchangeable (labile) hydrogen atoms (protons). Candidate peptides having amino acid compositions or sequences that do not contain the observed number of exchangeable protons are eliminated. In another embodiment, synthesis of a portion of the peptides in a library of peptides is terminated after each coupling step, whereby a set of sequentially truncated fragments of each peptide is formed. Thus the sequence of the peptide can be determined by determining the difference in the molecular weight between each peptide or fragment thereof and the sequentially smaller fragment of the peptide.
Why it is here
Selectide: candidate sequences from mass spectrometric analysis pruned by counting reactive groups or exchangeable protons.
Inventors (4)
Nikolai Sepetov, Olga Issakova, Viktor Krehnak, Michal Lebl
An inventor links to an author page only where the same person is evident, never on a name alone.
Cited by catalogued patents (1)
- US6271037B1 Method and product for the sequence determination of peptides using a mass spectrometer
Cited by (45 patent families, 33 organisations)
- Target Discovery company: US6379971B1, US20030119069A1, US6716636B1, US6764817B1, DK1358458T3
- Washington State University Research Foundation academic: US5854388A, US6022696A, EP2043675A2, US8236761B2
- Syngenta Participations company: US6969757B2, US7166436B2, US6800449B1
- Agilent Technologies company: US7457708B2, US8507285B2
- Palatin Technologies company: US6331285B1, US7385025B2
- Palo Alto Research Center academic: US7429727B2, US8108153B2
- Agency for Science, Technology and Research company: WO2011010964A1
- Arqule company: US5712171A
- Carta Proteomics company: US6291189B1
- Duke University academic: US6734023B1
- Exsar company: US6599707B1
- Ge Healthcare Bio-Sciences company: US7074570B2
- George Yefchak company: US20080073499A1
- Irm company: US20030139885A1
- Jean-Louis Dasseux company: US6037323A
- Ladine James R company: US20020068366A1
- North Carolina State University academic: WO2014093196A1
- Novo Nordisk A/S company: US5854211A
- Oxford Glycosciences (Uk) company: US6963807B2
- Oxford Glycosciences Uk company: GB9710582D0
- Pacific Northwest Biotechnology company: US7118747B2
- Parallax Biosystems company: US20070134733A1
- Praecis Pharmaceuticals, Inc., Cambridge company: DE69628194T2
- Rhomed company: US5891418A
- Shimadzu Res Lab Europe company: GB0212470D0
- Syn X Pharma company: US6891154B2
- Tarr company: US5824556A
- Triad Liquidating company: US7653490B2
- Univ Duke company: ATE393910T1
- Universite D’ottawa/ University of Ottawa academic: CA2224066A1
- University of California academic: US5658739A
- Yakhini Zohar H company: US20080090236A1
- 株式会社日立製作所 company: JP3885020B2
Every family, of any applicant, that cites this one, as Google Patents lists them; an assignee is given its English name.